Can a chemo boost outsmart lingering colon cancer cells?
NCT ID NCT05534087
First seen Jul 31, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This trial is testing whether giving a stronger chemotherapy regimen (mFOLFIRINOX) early can improve outcomes for people with stage II-III colon cancer who still have signs of cancer DNA in their blood during standard adjuvant chemo. Participants are randomly assigned to either receive the intensified treatment or continue with standard chemo. The goal is to see if the intensified approach can reduce the chance of cancer returning or spreading.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Intensified chemotherapy with modified FOLFIRINOX regimen
- What this could lead to
- If successful, this approach could offer a more effective treatment strategy for colon cancer patients at high risk of recurrence, potentially improving their chances of staying cancer-free.
- What could go wrong
- The intensified regimen may cause more side effects, and it's uncertain whether it will improve survival compared to standard treatment. The trial is still ongoing, and results are not yet available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ajou University Hospital
RECRUITINGSuwon, South Korea
-
Asan Medical Center
RECRUITINGSeoul, South Korea
-
Chonnam National University Hwasun Hospital
RECRUITINGHwasun, South Korea
-
Chung-Ang University Hospital
RECRUITINGSeoul, South Korea
Contact Email: •••••@•••••
-
Dong-A University Hospital
RECRUITINGBusan, South Korea
-
Korea University Guro Hospital
RECRUITINGSeoul, South Korea
-
Kyungpook National University Chilgok Hospital
RECRUITINGDaegu, South Korea
-
National Cancer Center
RECRUITINGGoyang, South Korea
-
SMG-SNU Boramae Medical Center
RECRUITINGSeoul, South Korea
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, South Korea
-
Severance Hospital
RECRUITINGSeoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Can artificial intelligence think like a cancer tumor board?
- A new clue in the fight against colorectal cancer recurrence?
- Can radiation plus immunotherapy make colon tumors disappear before surgery?
- Does practice make perfect? a study probes how a Surgeon's learning curve impacts cancer surgery success
- A simple breath test might spot multiple cancers before symptoms appear